Trimethoprim-sulphamethoxazole therapy and folate nutrition.
D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects*; D001772:Blood Cell Count; D001856:Bone Marrow Examination; D001996:Bronchopneumonia / Q000150:complications / Q000188:drug therapy; D005365:FIGLU Test; D005260:Female; D005492:Folic Acid / Q000097:blood; D005493:Folic Acid Antagonists / Q000009:adverse effects*; D005494:Folic Acid Deficiency / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D006454:Hemoglobins / Q000097:blood; D006801:Humans; D007223:Infant; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D011247:Pregnancy; D011488:Protein Deficiency / Q000150:complications; D011645:Puerperal Infection / Q000188:drug therapy; D011743:Pyrimidines / Q000009:adverse effects*; D013420:Sulfamethoxazole / Q000009:adverse effects* / Q000627:therapeutic use; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D006454:Hemoglobins; D011743:Pyrimidines; D005492:Folic Acid; D014295:Trimethoprim; D013420:Sulfamethoxazole